Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

589 results
Display

Helicobacter pylori testing in a population of Korean patients with pernicious anemia

Song IC, Lee MW, Baek SW, Ryu H, Choi YS, Jo DY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of 7- and 14-Day Eradication Therapy for Helicobacter pylori with First- and Second-Line Regimen: Randomized Clinical Trial

Kim TH, Park JM, Cheung DY, Oh JH

BACKGROUND: Although Helicobacter pylori is a key cause of gastric cancer development, its eradication rate has been decreasing by standard regimens. For successful eradication, duration of treatment has been issued...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluating Diagnostic Tests for Helicobacter pylori Infection Without a Reference Standard: Use of Latent Class Analysis

Jekarl DW, Choi H, Kim JY, Lee S, Gweon TG, Lee HK, Kim Y

Evaluation of diagnostic tests requires reference standards, which are often unavailable. Latent class analysis (LCA) can be used to evaluate diagnostic tests without reference standards, using a combination of observed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change in Size of Gastric Hyperplastic Polyps after Helicobacter pylori Eradication: A Prospective Study

Yoo AY, Park JJ, Joo MK, Lee BJ, Chun HJ, Lee SW

BACKGROUND/AIMS: Helicobacter pylori (H. pylori) eradication is known to be effective for reducing the size of gastric hyperplastic polyps (HPPs). This study investigated the change in size of gastric HPPs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Eradication Therapy for Helicobacter pylori with Diagnostic Test for Clarithromycin Resistance

Kim YJ, Chung WC

Addressing the increasing antibiotic resistance, including clarithromycin resistance, which affects Helicobacter pylori (H. pylori) eradication therapy, is a challenge for clinicians. Antibiotic resistance is the main reason for H. pylori...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Eradication after Endoscopic Resection of Gastric Epithelial Neoplasms

Choi JM, Kim SG

Endoscopic submucosal dissection is widely accepted as standard treatment for early gastric cancer; however, long-term management of metachronous gastric cancer after endoscopic resection is an important issue that is gaining...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness of Helicobacter pylori Eradication before Endoscopic Resection

Ahn JY

Helicobacter pylori (H. pylori) infection can cause gastric dysplasia and cancer via chronic inflammatory changes in the gastric mucosa that may lead to gastric atrophy and intestinal metaplasia. Many epidemiologic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can Helicobacter pylori Eradication Regress Gastric Hyperplastic Polyps?

Lee JY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proteome Analysis of Alkylhydroxide Peroxidase-Deficient Isogenic Mutant of Helicobacter pylori 26695

Lee WK, Baik SC, Shin MK, Jung M, Park JS, Ha JH, Lee DH, Kim MJ, Shin JI, Kang HL

In order to investigate the antioxidant effect of alkylhydroxide peroxidase (ahpC) of Helicobacter pylori (H. pylori) 26695, an ahpC-deficient mutant (H. pylori 26695 ahpC::cat) was generated. ahpC-deficient mutant was grown...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Infection in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Shin SP, Bang CS, Lee JJ, Baik GH

BACKGROUND/AIMS: Insufficient systematic reviews were conducted in the previous meta-analyses about the prevalence of Helicobacter pylori infection in patients with chronic kidney disease (CKD). The aim of this study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease

Ahn JY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Study of probiotic and simvastatin additive effect on Helicobacter pylori eradication rate

Parsi A, Biuseh M, Mohammadi , Hajiani E, Hashemi SJ, Saeidian H, Biuseh M

BACKGROUND: Helicobacter pylori infection is a major cause of chronic gastritis, peptic, mucosa associated lymphoid tissueMisdiagnosed as lymphoma and gastric cancer. The eradication rate of H. pylori with standard treatments...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibitory Effects of β-caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study

Shim HI, Song DJ, Shin CM, Yoon H, Park YS, Kim N, Lee DH

BACKGROUND/AIMS: Helicobacter pylori (H. pylori) infections, which cause a variety of gastrointestinal symptoms, are common in South Korea. Recent reports have shown a decline in the H. pylori eradication rates....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Helicobacter pylori Immunoglobulin G Levels and Gastric Mucosal Atrophy after Successful Eradication of Helicobacter pylori

Kim JH, Lee JS, Kwon YH, Jeon SW, Nam SY, Jin S

BACKGROUND/AIMS: Limited information is available about the relationship between Helicobacter pylori (H. pylori) immunoglobulin (Ig) G and serum pepsinogen (pepsinogen [PG], a marker of gastric mucosal atrophy) concentrations after H....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea

Kim BJ, Lee H, Lee YC, Jeon SW, Kim GH, Kim HS, Sung JK, Lee DH, Kim HU, Park MI, Choi IJ, Yoon SM, Kim SW, Baik GH, Lee JY, Kim JI, Kim SG, Kim J, Lee J, Kim JG, Kim JJ, Korean College of Helicobacter and Upper Gastrointestinal Research

BACKGROUND/AIMS: This nationwide, multicenter prospective randomized controlled trial aimed to compare the efficacy and safety of 10-day concomitant therapy (CT) and 10-day sequential therapy (ST) with 7-day clarithromycin-containing triple therapy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Citric Acid on Accuracy of ¹³C-Urea Breath Test after Helicobacter pylori Eradication Therapy in a Region with a High Prevalence of Atrophic Gastritis

Kwon YH, Kim N, Yoon H, Shin CM, Park YS, Lee DH

BACKGROUND/AIMS: The validity of ¹³C-urea breath test (¹³C-UBT) for Helicobacter pylori detection is influenced by atrophic gastritis. The aim of this study was to evaluate the effect of citric acid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam

Van Khien , Thang DM, Hai TM, Duat NQ, Khanh PH, Ha DT, Binh TT, Dung HD, Trang TT, Yamaoka Y

Antibiotic resistance is the most important factor leading to the failure of eradication regimens. This review focuses on the prevalence of Helicobacter pylori primary and secondary resistance to clarithromycin, metronidazole,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in the Treatment Strategies for Helicobacter pylori Infection in Children and Adolescents in Korea

Jun JS, Seo JH, Park JS, Rhee KH, Youn HS

The policies developed for the treatment of Helicobacter pylori infection in adults may not be the most suitable ones to treat children and adolescents. Methods used to treat children and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis

Chang YW, Ko WJ, Oh CH, Park YM, Oh SJ, Moon JR, Cho JH, Kim JW, Jang JY

BACKGROUND/AIMS: The eradication rate of the first-line triple therapy (a proton pump inhibitor, clarithromycin, and amoxicillin) for Helicobacter pylori infection has gradually decreased in Korea. We evaluated whether clinical parameters,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders

Kountouras J, Gavalas E, Doulberis , Polyzos SA, Papaefthymiou A, Touloumtzi M, Vardaka E, Kountouras K, Papanikolopoulou K, Katsinelos P

  • KMID: 2454646
  • J Neurogastroenterol Motil.
  • 2019 Jul;25(3):473-474.
  • doi: 10.5056/jnm19033
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr